Intro:
Indian drug regulators are waiving off clinical trial requirements for some drugs already approved in the US, the UK, Japan, Australia, Canada and the European Union.
Officials say this will drastically reduce the wait time for patients - and save the government and private firms crucial resources.
Ishan Garg has more from New Delhi.
IN: The waiver...
OUT: SOC
Duration: 36 seconds
http://www.fsnradionews.com/feeds/0809-IndiaDrugFacilities-ig-gen.mp3